MEDAREX INC. MEDX (NASDAQ)

$ 5.38
11/18/2008 20:09
Sponsored by
Click here!
Change: unch (unch%)
Volume: 1,056,074

Avg. Volume: 1338259
P/E Ratio: 0
EPS (Annual): -0.38
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 128,140
Institutional Shareholders: 83.30%
Last: 5.38
Change: unch (unch%)
Prev. Close: 5.38
Open: 5.49
Day's Range: 5.25 - 5.61
52wk Range: 4.29 - 14.00
Market Value: 703,490
Beta: .84
12-month EPS Change: 0.00%
Total Return Last 12 Months: -54.13%
Total Return Last 3 Years: -41.86%
Total Return Last 5 Years: -13.92%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on MEDX

Medarex says drug combo reduced diarrhea in trial

(NEW YORK)Medarex Inc. and the Massachusetts Biologics Laboratories said Monday that their two drug candidates reduced diarrhea in a clinical trial compared with a placebo.READ MORE
Nov 03, 2008 1:54PM
Keywords: MEDX

Premarket roundup: Jobless claims, foreign trade

Among the premarket activity stories for Thursday, Sept. 11, from AP Financial News: WASHINGTON (AP)--Government data is expected to show that the number of newly laid-off people f...READ MORE
Sep 11, 2008 9:25AM
Keywords: WFMI, MEDX, FUL, GS

Ahead of the Bell: Medarex downgraded

(NEW YORK)A JPMorgan analyst downgraded shares of Medarex Inc. Thursday, saying the stock will trade in place until the second half of 2009, when Medarex reports critical late-stage trial da...READ MORE
Sep 11, 2008 7:44AM
Keywords: MEDX, BMY

Medarex gets milestone payment from Pfizer

(PRINCETON, N.J.)Medarex Inc. said Monday it received a milestone payment after Pfizer Inc. planned to begin clinical trials of a product Pfizer developed using Madera's ultimo technology.READ MORE
Sep 08, 2008 12:21PM
Keywords: MEDX, PFE

Medarex posts wider 2Q loss on lower revenue

(PRINCETON, N.J.)Biotechnology company Medarex Inc. said late Tuesday its second-quarter loss widened on a mix of lower revenue and a charge related to its affiliate Avant Immunotherapeutics.READ MORE
Aug 06, 2008 1:57PM
Keywords: MEDX, AVAN

Medarex shares fall on concerns over melanoma data

(NEW YORK)Shares of biotechnology company Medarex Inc. fell Monday after analysts expressed concerns over the company's late-stage melanoma drug candidate ipilimumab.READ MORE
Jun 02, 2008 7:31PM
Keywords: MEDX, BMY

Movers roundup: Medarex, Harris

Among the stock activity stories for Monday, June 2, from AP Financial News: NEW YORK (AP)--Shares of biotechnology company Medarex Inc. fell Monday after analysts expressed concer...READ MORE
Jun 02, 2008 2:18PM
Keywords: MEDX, HRS, MWA, NTY, CTRP, ZQK
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +9.80 56.34
GILEAD SCIENCES -3.90 45.22
CELGENE CORPORA -10.10 57.57
STEMCELLS INC. -61.50 1.13
BIOGEN IDEC INC -30.40 43.80